We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

EUROIMMUN AG

Euroimmun (part of Revvity) is an international provider of medical laboratory products for autoimmune, infection, al... read more Featured Products: More products

Download Mobile App




Novel Automated IIFT System Enables Cutting-Edge Diagnostic Analysis

By LabMedica International staff writers
Posted on 02 Jun 2023

A newly-launched automated indirect immunofluorescence test (IIFT) system for autoimmune disease diagnostics offers an all-in-one solution to enhance the efficiency of the complete IIFT process, comprising sample preparation, incubation, washing, and mounting of slides as well as image acquisition and analysis. More...

EUROIMMUN (Lübeck, Germany) has introduced the UNIQO 160 (CE-IVDR automated IIFT system, a unique benchtop device that combines a fully automated processing system with a high-quality microscope and can be seamlessly integrated into existing diagnostics laboratory workflows. The device boasts the capability to process 160 primary samples and 18 slides per run, while automatically identifying individual samples, reagents, and slides using barcode recognition. This ensures a high level of reliability and traceability of both materials and samples. Additionally, the UNIQO 160 applies a mounting medium and a cover glass for incubated slides to prevent them from drying out, which is a crucial step for achieving high-quality fluorescence images.

The UNIQO 160 generates brilliant fluorescence images using its optical system's autofocus feature and three automatically interchangeable objectives (4x, 10x, 20x). The captured images are then relayed to the system's EUROLabOffice 4.0 middleware for evaluation. Ideal for medium-throughput laboratories, the UNIQO 160 is the latest addition to EUROIMMUN's range of automated laboratory solutions, joining the likes of the EUROPattern Microscope Live, EUROLabWorkstation IFA, and Sprinter XL systems. The UNIQO 160 is also expected to be compatible with the forthcoming EUROPattern Classifier, a software platform that employs cutting-edge pattern classification using artificial intelligence to assist in the final evaluation and suggest analytical results.

“Traditional IIFT processing can be tedious and time-consuming, requiring the expertise of specially trained lab technicians and a dark room,” said Dr. Bianca Huth, chief technology officer of EUROIMMUN. “The design of the UNIQO 160 system and technologies built into it alleviate laboratories of many common challenges by reducing hands-on time and creating efficiencies through end-to-end automation.”

Related Links:
EUROIMMUN 


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Neonatal Heel Incision Device
Tenderfoot
Manual Pipetting Aid
Pipette Controllers macro
New
Gastrointestinal Panel
Xpert® GI Panel
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Researchers from the Department of Chemistry at Aarhus University have developed and tested a new technology that can identify and measure the concentration of pharmaceuticals in under 10 minutes. Today, this process takes up to an hour. That is critical waiting time for patients suffering from a stroke. (Image Credit: Aarhus University)

Point-of-Care Blood Test Could Speed Treatment Decisions in Acute Stroke

Minutes can shape treatment decisions in emergency stroke care, particularly when physicians need to know whether a patient is taking anticoagulants before administering clot-dissolving therapy.... Read more

Microbiology

view channel
Image: The clearance also broadens QIAstat-Dx\'s infectious disease testing menu in the U.S., which already includes panels for respiratory and gastrointestinal infections, as well as meningitis and encephalitis (Photo courtesy of Qiagen)

One-Hour Molecular Panel Expands Bloodstream Infection Testing for Gram-Negative Pathogens

Bloodstream infections can progress rapidly and lead to sepsis, organ failure, and death. In the United States, about 1.7 million adults develop sepsis each year, and at least 350,000 die during hospitalization... Read more

Industry

view channel
Image

Collaboration Combines AI Cognitive Assessment and RNA Blood Testing for Earlier Alzheimer’s Detection

Alzheimer’s disease is often identified only after substantial neurodegeneration, partly because current diagnostic pathways are fragmented and difficult to scale. As treatment shifts toward earlier intervention,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.